Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lysophospholipids | 17 | 2023 | 63 | 3.590 |
Why?
|
Sphingosine | 15 | 2023 | 71 | 3.300 |
Why?
|
Endothelial Cells | 16 | 2023 | 428 | 1.970 |
Why?
|
Lung | 22 | 2024 | 1170 | 1.790 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 11 | 2020 | 80 | 1.690 |
Why?
|
Amifostine | 3 | 2024 | 51 | 1.690 |
Why?
|
Endothelium, Vascular | 8 | 2018 | 435 | 1.650 |
Why?
|
Reactive Oxygen Species | 12 | 2024 | 480 | 1.630 |
Why?
|
Signal Transduction | 20 | 2020 | 3241 | 1.410 |
Why?
|
Pseudopodia | 3 | 2018 | 35 | 1.350 |
Why?
|
Paxillin | 2 | 2021 | 59 | 1.310 |
Why?
|
Pseudomonas Infections | 3 | 2019 | 95 | 1.250 |
Why?
|
Ventilator-Induced Lung Injury | 9 | 2023 | 31 | 1.220 |
Why?
|
Pneumonia | 4 | 2024 | 179 | 1.210 |
Why?
|
Capillary Permeability | 10 | 2015 | 130 | 1.210 |
Why?
|
Pseudomonas aeruginosa | 4 | 2020 | 194 | 1.200 |
Why?
|
Idiopathic Pulmonary Fibrosis | 5 | 2024 | 165 | 1.200 |
Why?
|
Mitochondrial Dynamics | 2 | 2021 | 53 | 0.980 |
Why?
|
Phospholipase D | 3 | 2020 | 12 | 0.960 |
Why?
|
Blood-Air Barrier | 3 | 2020 | 6 | 0.940 |
Why?
|
Lipopolysaccharides | 6 | 2021 | 286 | 0.930 |
Why?
|
Cadherins | 4 | 2023 | 151 | 0.900 |
Why?
|
Acute Lung Injury | 4 | 2018 | 60 | 0.880 |
Why?
|
Aldehyde-Lyases | 6 | 2021 | 15 | 0.830 |
Why?
|
Sphingolipids | 2 | 2018 | 20 | 0.830 |
Why?
|
Antigens, CD | 4 | 2020 | 458 | 0.790 |
Why?
|
Lung Injury | 2 | 2019 | 47 | 0.780 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2020 | 6 | 0.750 |
Why?
|
Receptors, Lysosphingolipid | 7 | 2023 | 36 | 0.740 |
Why?
|
Epigenesis, Genetic | 3 | 2019 | 479 | 0.710 |
Why?
|
Mice | 32 | 2024 | 11352 | 0.690 |
Why?
|
Hepatocyte Growth Factor | 2 | 2016 | 84 | 0.690 |
Why?
|
Phospholipids | 5 | 2012 | 111 | 0.670 |
Why?
|
Inflammation | 7 | 2019 | 920 | 0.670 |
Why?
|
Cells, Cultured | 17 | 2017 | 2818 | 0.640 |
Why?
|
Cell-Derived Microparticles | 1 | 2017 | 11 | 0.630 |
Why?
|
Anion Transport Proteins | 2 | 2016 | 10 | 0.630 |
Why?
|
Endothelium | 4 | 2012 | 59 | 0.620 |
Why?
|
Cartilage, Articular | 1 | 2017 | 67 | 0.600 |
Why?
|
NADPH Oxidases | 3 | 2016 | 81 | 0.600 |
Why?
|
Animals | 41 | 2024 | 26582 | 0.600 |
Why?
|
Bleomycin | 5 | 2024 | 98 | 0.590 |
Why?
|
Mice, Inbred C57BL | 16 | 2024 | 3092 | 0.590 |
Why?
|
Phosphorylation | 5 | 2021 | 1106 | 0.570 |
Why?
|
Cell Nucleus | 1 | 2018 | 579 | 0.550 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2015 | 30 | 0.520 |
Why?
|
Mitochondria | 4 | 2024 | 535 | 0.500 |
Why?
|
NADP | 1 | 2013 | 45 | 0.460 |
Why?
|
Pneumonia, Bacterial | 1 | 2013 | 28 | 0.450 |
Why?
|
Cell Movement | 1 | 2016 | 758 | 0.450 |
Why?
|
Guanine Nucleotide Exchange Factors | 6 | 2010 | 73 | 0.440 |
Why?
|
Free Radical Scavengers | 1 | 2011 | 59 | 0.410 |
Why?
|
Membrane Glycoproteins | 1 | 2013 | 428 | 0.380 |
Why?
|
Bronchoalveolar Lavage Fluid | 6 | 2024 | 121 | 0.380 |
Why?
|
Bronchopulmonary Dysplasia | 2 | 2020 | 39 | 0.370 |
Why?
|
Cell Cycle Proteins | 3 | 2020 | 388 | 0.370 |
Why?
|
Humans | 39 | 2024 | 86643 | 0.340 |
Why?
|
Hyperoxia | 2 | 2020 | 34 | 0.330 |
Why?
|
Adherens Junctions | 4 | 2020 | 34 | 0.330 |
Why?
|
Radiation-Protective Agents | 1 | 2008 | 96 | 0.320 |
Why?
|
Phosphatidylcholines | 6 | 2011 | 48 | 0.310 |
Why?
|
Cytokines | 4 | 2019 | 776 | 0.280 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2024 | 87 | 0.280 |
Why?
|
Placental Hormones | 1 | 2005 | 3 | 0.260 |
Why?
|
Fibroblasts | 3 | 2024 | 729 | 0.250 |
Why?
|
Thrombin | 4 | 2020 | 61 | 0.250 |
Why?
|
Phenazines | 1 | 2024 | 7 | 0.240 |
Why?
|
Gentian Violet | 1 | 2024 | 10 | 0.240 |
Why?
|
rac GTP-Binding Proteins | 3 | 2009 | 25 | 0.240 |
Why?
|
NAD | 1 | 2024 | 65 | 0.240 |
Why?
|
Cell Line | 6 | 2021 | 2468 | 0.240 |
Why?
|
Sirtuin 1 | 1 | 2024 | 32 | 0.240 |
Why?
|
Methanol | 2 | 2020 | 12 | 0.240 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2016 | 199 | 0.240 |
Why?
|
Alveolar Epithelial Cells | 2 | 2020 | 18 | 0.230 |
Why?
|
Benzenesulfonates | 1 | 2024 | 66 | 0.230 |
Why?
|
Mycoses | 1 | 2024 | 46 | 0.230 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2024 | 64 | 0.230 |
Why?
|
Pyrrolidines | 2 | 2020 | 58 | 0.230 |
Why?
|
Hematopoietic Stem Cells | 1 | 2005 | 292 | 0.220 |
Why?
|
Antioxidants | 3 | 2011 | 223 | 0.220 |
Why?
|
Aldehydes | 2 | 2020 | 17 | 0.220 |
Why?
|
Genetic Therapy | 1 | 2005 | 342 | 0.220 |
Why?
|
Gene Knockdown Techniques | 5 | 2015 | 236 | 0.220 |
Why?
|
Angiogenesis Inhibitors | 1 | 2005 | 311 | 0.220 |
Why?
|
Mice, Knockout | 7 | 2020 | 1924 | 0.210 |
Why?
|
Vascular Diseases | 1 | 2023 | 121 | 0.210 |
Why?
|
Pulmonary Artery | 5 | 2023 | 306 | 0.210 |
Why?
|
Gene Deletion | 2 | 2020 | 329 | 0.210 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2020 | 302 | 0.200 |
Why?
|
Histone Deacetylases | 2 | 2020 | 63 | 0.200 |
Why?
|
Tyrosine | 1 | 2021 | 133 | 0.200 |
Why?
|
Microfilament Proteins | 2 | 2013 | 208 | 0.200 |
Why?
|
Gene Expression Regulation | 4 | 2019 | 1920 | 0.190 |
Why?
|
Pulmonary Surfactant-Associated Protein C | 1 | 2020 | 3 | 0.190 |
Why?
|
Melanoma | 1 | 2005 | 459 | 0.190 |
Why?
|
Airway Remodeling | 1 | 2020 | 9 | 0.190 |
Why?
|
Plasmalogens | 1 | 2020 | 3 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 322 | 0.180 |
Why?
|
Iloprost | 2 | 2010 | 15 | 0.180 |
Why?
|
Apoptosis | 5 | 2021 | 1683 | 0.180 |
Why?
|
Male | 19 | 2020 | 40965 | 0.170 |
Why?
|
Regeneration | 1 | 2020 | 143 | 0.170 |
Why?
|
Hypertension, Pulmonary | 1 | 2023 | 346 | 0.170 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 247 | 0.160 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 2 | 2009 | 107 | 0.160 |
Why?
|
Simvastatin | 1 | 2018 | 106 | 0.160 |
Why?
|
Hyaluronan Receptors | 1 | 2017 | 36 | 0.160 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2005 | 878 | 0.160 |
Why?
|
Chondrocytes | 1 | 2017 | 60 | 0.160 |
Why?
|
Oxidation-Reduction | 5 | 2010 | 373 | 0.160 |
Why?
|
Interleukin-1beta | 1 | 2017 | 78 | 0.160 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 296 | 0.150 |
Why?
|
Cortactin | 1 | 2016 | 11 | 0.150 |
Why?
|
Membrane Proteins | 4 | 2023 | 1196 | 0.140 |
Why?
|
Oxidative Stress | 3 | 2023 | 447 | 0.140 |
Why?
|
Cell Proliferation | 2 | 2023 | 1578 | 0.140 |
Why?
|
Cell Cycle | 1 | 2018 | 502 | 0.140 |
Why?
|
Respiration, Artificial | 2 | 2009 | 334 | 0.140 |
Why?
|
RNA, Small Interfering | 7 | 2013 | 547 | 0.140 |
Why?
|
Disease Models, Animal | 7 | 2020 | 2232 | 0.140 |
Why?
|
Catenins | 2 | 2012 | 11 | 0.130 |
Why?
|
Cytoskeleton | 4 | 2012 | 193 | 0.130 |
Why?
|
Tyrphostins | 1 | 2015 | 7 | 0.130 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2015 | 31 | 0.130 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 266 | 0.120 |
Why?
|
Lung Diseases | 1 | 2016 | 263 | 0.120 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2013 | 14 | 0.120 |
Why?
|
Phosphoproteins | 2 | 2012 | 254 | 0.120 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 1384 | 0.120 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2013 | 25 | 0.120 |
Why?
|
rap1 GTP-Binding Proteins | 2 | 2012 | 13 | 0.120 |
Why?
|
Tight Junctions | 2 | 2012 | 149 | 0.120 |
Why?
|
NADPH Oxidase 2 | 1 | 2013 | 20 | 0.120 |
Why?
|
p21-Activated Kinases | 2 | 2010 | 15 | 0.110 |
Why?
|
Blotting, Western | 4 | 2013 | 782 | 0.110 |
Why?
|
NADPH Oxidase 4 | 1 | 2013 | 15 | 0.110 |
Why?
|
Chemotaxis | 1 | 2013 | 72 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 262 | 0.110 |
Why?
|
Transcription Factors | 1 | 2020 | 1565 | 0.110 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2013 | 214 | 0.100 |
Why?
|
Telomere-Binding Proteins | 1 | 2011 | 14 | 0.100 |
Why?
|
Cyclic AMP | 2 | 2009 | 273 | 0.100 |
Why?
|
Rho Guanine Nucleotide Exchange Factors | 2 | 2010 | 16 | 0.100 |
Why?
|
Interleukin-6 | 2 | 2010 | 256 | 0.100 |
Why?
|
Immunoglobulins | 1 | 2011 | 148 | 0.100 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 163 | 0.100 |
Why?
|
Atrial Natriuretic Factor | 1 | 2010 | 39 | 0.100 |
Why?
|
Sulfones | 2 | 2020 | 43 | 0.090 |
Why?
|
rho GTP-Binding Proteins | 1 | 2010 | 54 | 0.090 |
Why?
|
Caveolin 1 | 1 | 2009 | 20 | 0.090 |
Why?
|
Membrane Microdomains | 1 | 2009 | 54 | 0.080 |
Why?
|
Receptors, LDL | 1 | 2009 | 53 | 0.080 |
Why?
|
Fluorescent Antibody Technique | 2 | 2009 | 316 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2010 | 403 | 0.080 |
Why?
|
DNA, Complementary | 2 | 2005 | 393 | 0.080 |
Why?
|
Dinoprostone | 1 | 2007 | 69 | 0.080 |
Why?
|
Epoprostenol | 1 | 2007 | 46 | 0.070 |
Why?
|
Fibronectins | 2 | 2020 | 93 | 0.070 |
Why?
|
Epithelial Cells | 2 | 2021 | 669 | 0.070 |
Why?
|
Female | 6 | 2020 | 44532 | 0.070 |
Why?
|
rac1 GTP-Binding Protein | 3 | 2013 | 48 | 0.070 |
Why?
|
Asthma | 1 | 2013 | 955 | 0.070 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2005 | 24 | 0.070 |
Why?
|
Retroviridae | 1 | 2005 | 79 | 0.060 |
Why?
|
Transgenes | 1 | 2005 | 180 | 0.060 |
Why?
|
Gene Transfer Techniques | 1 | 2005 | 152 | 0.060 |
Why?
|
T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 3 | 2009 | 7 | 0.060 |
Why?
|
ADAM10 Protein | 1 | 2023 | 7 | 0.060 |
Why?
|
DNA Primers | 1 | 2005 | 543 | 0.060 |
Why?
|
Cloning, Molecular | 1 | 2005 | 646 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2005 | 190 | 0.060 |
Why?
|
Electric Impedance | 3 | 2009 | 104 | 0.060 |
Why?
|
Transplantation, Heterologous | 1 | 2005 | 363 | 0.060 |
Why?
|
Vascular Remodeling | 1 | 2023 | 21 | 0.060 |
Why?
|
Staining and Labeling | 1 | 2024 | 165 | 0.060 |
Why?
|
Genetic Vectors | 1 | 2005 | 439 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2019 | 912 | 0.060 |
Why?
|
Ribonucleases | 1 | 2003 | 92 | 0.060 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2023 | 93 | 0.060 |
Why?
|
Protein Transport | 2 | 2016 | 411 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 879 | 0.060 |
Why?
|
Mice, Transgenic | 2 | 2019 | 1540 | 0.060 |
Why?
|
Zonula Occludens-1 Protein | 2 | 2012 | 70 | 0.050 |
Why?
|
Acyltransferases | 1 | 2021 | 41 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2005 | 376 | 0.050 |
Why?
|
Transforming Growth Factor beta | 2 | 2013 | 301 | 0.050 |
Why?
|
Cell Count | 1 | 2020 | 195 | 0.050 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2020 | 75 | 0.050 |
Why?
|
RNA Interference | 2 | 2013 | 369 | 0.050 |
Why?
|
Random Allocation | 2 | 2010 | 332 | 0.040 |
Why?
|
Pyrazoles | 1 | 2020 | 153 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 1991 | 0.040 |
Why?
|
Animals, Newborn | 1 | 2020 | 510 | 0.040 |
Why?
|
Virulence | 1 | 2019 | 271 | 0.040 |
Why?
|
Oligopeptides | 2 | 2010 | 179 | 0.040 |
Why?
|
Down-Regulation | 1 | 2020 | 504 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2019 | 183 | 0.040 |
Why?
|
Pyridines | 1 | 2020 | 310 | 0.040 |
Why?
|
beta Catenin | 2 | 2011 | 251 | 0.040 |
Why?
|
Smoking | 1 | 2021 | 609 | 0.040 |
Why?
|
Actins | 2 | 2013 | 451 | 0.040 |
Why?
|
DNA Damage | 1 | 2019 | 366 | 0.040 |
Why?
|
Histone Deacetylase 2 | 1 | 2016 | 6 | 0.040 |
Why?
|
Histone Deacetylase 1 | 1 | 2016 | 13 | 0.040 |
Why?
|
Acetylation | 1 | 2016 | 121 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2016 | 51 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 456 | 0.040 |
Why?
|
Drug Design | 1 | 2016 | 124 | 0.030 |
Why?
|
Microvessels | 1 | 2016 | 70 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2020 | 1753 | 0.030 |
Why?
|
Gene Expression | 1 | 2020 | 1284 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2016 | 314 | 0.030 |
Why?
|
Ligands | 1 | 2016 | 433 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2016 | 692 | 0.030 |
Why?
|
Histones | 1 | 2016 | 311 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2013 | 55 | 0.030 |
Why?
|
Phenotype | 1 | 2020 | 2378 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 192 | 0.030 |
Why?
|
Allergens | 1 | 2013 | 179 | 0.030 |
Why?
|
Collagen | 1 | 2013 | 269 | 0.030 |
Why?
|
Protein Kinase C | 1 | 2013 | 270 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2013 | 425 | 0.030 |
Why?
|
Occludin | 1 | 2011 | 66 | 0.030 |
Why?
|
Bronchoalveolar Lavage | 1 | 2010 | 26 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2010 | 102 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2012 | 420 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 125 | 0.020 |
Why?
|
Immunoblotting | 1 | 2010 | 268 | 0.020 |
Why?
|
Time Factors | 2 | 2009 | 5210 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2010 | 103 | 0.020 |
Why?
|
8-Bromo Cyclic Adenosine Monophosphate | 1 | 2009 | 13 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2011 | 286 | 0.020 |
Why?
|
Microtubules | 1 | 2010 | 119 | 0.020 |
Why?
|
Rats | 2 | 2008 | 3990 | 0.020 |
Why?
|
Gene Silencing | 1 | 2009 | 172 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2010 | 248 | 0.020 |
Why?
|
rho-Associated Kinases | 1 | 2010 | 159 | 0.020 |
Why?
|
Rats, Inbred BN | 1 | 2008 | 37 | 0.020 |
Why?
|
Paclitaxel | 1 | 2010 | 460 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 2007 | 10 | 0.020 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2007 | 18 | 0.020 |
Why?
|
NF-kappa B | 1 | 2010 | 444 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2013 | 1458 | 0.020 |
Why?
|
Phosphatidic Acids | 1 | 2006 | 4 | 0.020 |
Why?
|
Permeability | 1 | 2007 | 137 | 0.020 |
Why?
|
Phosphatidylserines | 1 | 2006 | 20 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2010 | 683 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2006 | 408 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2006 | 223 | 0.020 |
Why?
|
CD146 Antigen | 1 | 2005 | 4 | 0.020 |
Why?
|
Immunomagnetic Separation | 1 | 2005 | 8 | 0.020 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2005 | 14 | 0.020 |
Why?
|
Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2005 | 44 | 0.020 |
Why?
|
von Willebrand Factor | 1 | 2005 | 37 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2005 | 503 | 0.020 |
Why?
|
Carbon Tetrachloride | 1 | 2003 | 7 | 0.010 |
Why?
|
Malondialdehyde | 1 | 2003 | 27 | 0.010 |
Why?
|
Glutathione Peroxidase | 1 | 2003 | 24 | 0.010 |
Why?
|
Catalase | 1 | 2003 | 48 | 0.010 |
Why?
|
Lipid Peroxidation | 1 | 2003 | 44 | 0.010 |
Why?
|
Alanine Transaminase | 1 | 2003 | 73 | 0.010 |
Why?
|
Aspartate Aminotransferases | 1 | 2003 | 73 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2003 | 111 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 2003 | 158 | 0.010 |
Why?
|
Cholesterol | 1 | 2005 | 356 | 0.010 |
Why?
|
Superoxide Dismutase | 1 | 2003 | 177 | 0.010 |
Why?
|
Transfection | 1 | 2003 | 896 | 0.010 |
Why?
|
Cell Survival | 1 | 2003 | 969 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 639 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 1961 | 0.010 |
Why?
|
Oxygen | 1 | 2003 | 726 | 0.010 |
Why?
|
Liver | 1 | 2003 | 1230 | 0.010 |
Why?
|
Cohort Studies | 1 | 2005 | 2767 | 0.010 |
Why?
|
Obesity | 1 | 2005 | 963 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2003 | 2426 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2005 | 827 | 0.010 |
Why?
|
Aged | 1 | 2013 | 18415 | 0.010 |
Why?
|
Middle Aged | 1 | 2013 | 25028 | 0.010 |
Why?
|